Source: Everyday Health Type 2 Diabetes/GLP-1 Patient Survey, N= 501, August 5-13, 2026
EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
News
Among people with type 2 diabetes, stigma is widespread, a new survey found. Certain groups may be especially prone to these negative experiences and comments, however.
Adobe Stock
By
Moira Lawler
Published on October 27, 2026
by
Sandy Bassin, MD
Add us on Google
GLP-1 use is widespread. Fifteen percent of U.S. adults have taken a GLP-1 at some point, according to a recent Gallup poll. [...] One explanation is that patients may see positive health changes and become more comfortable and confident in their treatment decision. “Patients may initially worry about how family, friends, or colleagues will react to their decision to use medication, and as treatment becomes part of their routine, they may become less concerned about those reactions,” Shukla says.
leave a reply